1. Home
  2. SINT vs HKPD Comparison

SINT vs HKPD Comparison

Compare SINT & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SiNtx Technologies Inc.

SINT

SiNtx Technologies Inc.

HOLD

Current Price

$1.63

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

HKPD

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

HOLD

Current Price

$0.13

Market Cap

9.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SINT
HKPD
Founded
1996
2016
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Other Pharmaceuticals
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
9.2M
IPO Year
2007
2024

Fundamental Metrics

Financial Performance
Metric
SINT
HKPD
Price
$1.63
$0.13
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
46.2K
3.3M
Earning Date
05-13-2026
08-14-2026
Dividend Yield
N/A
N/A
EPS Growth
59.45
N/A
EPS
N/A
N/A
Revenue
$1,018,000.00
N/A
Revenue This Year
$30.26
N/A
Revenue Next Year
$413.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.40
$0.14
52 Week High
$5.14
$1.82

Technical Indicators

Market Signals
Indicator
SINT
HKPD
Relative Strength Index (RSI) 46.12 21.83
Support Level $1.49 N/A
Resistance Level $1.90 $0.71
Average True Range (ATR) 0.07 0.06
MACD 0.00 -0.03
Stochastic Oscillator 34.78 1.00

Price Performance

Historical Comparison
SINT
HKPD

About SINT SiNtx Technologies Inc.

SINTX Technologies Inc is an advance ceramics company that develops, manufactures, and commercializes silicon nitride biomaterials, composites, devices, and related technologies for medical and other high-value applications. It provides biomedical solutions for medical devices specializing in silicon nitride (Si3N4) for musculoskeletal and antipathogenic applications. It also manufactures silicon nitride parts for customers in the electrical, aerospace, and other industrial sectors. The company is a globalised leader in the research, development, and manufacturing of silicon nitride, and its products have been implanted in humans. The Company operates as one operating segment.

About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.

Share on Social Networks: